<DOC>
	<DOCNO>NCT01841801</DOCNO>
	<brief_summary>To assess safety tolerability extend wear experimental air-activated self adhesive patch .</brief_summary>
	<brief_title>Evaluation Experimental Commercial Air-Activated , Adhesive Backed Heat Patches</brief_title>
	<detailed_description />
	<criteria>Participants 18 70 year age ; must general good health ; must absence visible disease might confuse skin reaction test material ; back region must free excessive hair , cut , tatoos , aberration ; must understand sign Informed Consent ; must consider dependable able follow direction ; Participants assign thermocouple must willing restrict activity 8 hour patch wear time thermocouples come loose ; Participants assign thermocouple must willing wear pouch contain thermostat thermocouple wire entire 8 hour period return study supply site visit 15 . If item return subject may invoice value unit ; must willing wear topical product lotion , sunscreen , etc . test area participate study ; must agree use adequate mean birth control include : abstinence , partner vasectomy , Intrauterine Device , hormonal implant devices/injections , regular use birth control pill , birth control patch condom spermicidal agent ; Participants willing come day CLEAN back ; Participants 55 year age old , agree supply tshirt wear visit two marked marker , use tshirt supply others morning visit ( visit 4 , 6 , 8 , 10 , 12 , 14 ) . Participants know skin sensitivity adhesion product ; Participants skin abnormality likely aggravate study material dermatological disease infection , rash , atrophic , fragile , abnormally dry skin , cuts abrasion treatment site ; Participants pregnant nursing , oral interview ; Participants diabetes poor circulation ; Participants unable tolerate condition protocol ; Participants view investigator suitable study ; Participants active skin cancer include basal cell carcinoma , cancer within one year ; Participants currently participate another clinical trial ; Participants routinely use antiinflammatory medication ( within 5 day study start ( 81mg aspirin okay ) ) immunosuppressive antihistamine medication within 3 week prior study start ( steroid nose/eye drop ok ) ; Participants currently use allergy injection ; Participants history severe asthma ; Participants active uncontrolled immunologic disorder i.e . AIDS , HIV positive , systemic lupus erythematosus , rheumatoid arthritis ; Participants uncontrolled thyroid disease ; Participants clinically significant chronic illness could place subject increase risk participation result inappropriate dermal response study ; Participants use topical medication test site within past 14 day ; Participants low midline abdominal pinnicula may interfere heat patch/wrap application evaluation ; Participants pacemaker , defibrillator implantable medical device ; Participants allergies latex , polyethylene , polypropylene , nickel , chromium aluminum .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>